查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679320

2030 年分子农业市场预测：按类型、规模、作物来源、技术、应用、最终用户和地区进行的全球分析

Molecular Farming Market Forecasts to 2030 - Global Analysis By Type (Plant-Based, Animal-Based, and Other Types), Scale, Crop Source, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球分子农业市场价值为 5.3175 亿美元，预计到 2030 年将达到 13.7103 亿美元，预测期内的复合年增长率为 17.1%。

分子农业是利用基因改造植物、微生物和藻类生产有用的生物产品（包括蛋白质、疫苗、酵素和生质燃料）的过程。特定基因可以被引入生物体，使其能够合成所需的化学物质，从而提供一种可扩展且廉价的传统生产技术替代方案。分子农业在製药、农业和工业领域的应用日益广泛。它加速了生物技术的进步，并有助于为能源、食品生产和医学提供永续的解决方案。

生物製药需求不断成长

随着糖尿病、癌症和心血管疾病等慢性疾病的发生率上升，对生物製药的需求也日益增长。生物製药提供有针对性的有效治疗方法，推动分子农业市场的成长。此外，生物技术和基因工程的进步使得利用植物系统生产复杂的蛋白质和抗体成为可能。这些系统通常比传统方法更具成本效益和扩充性。不断成长的生物製药市场为分子农业技术的发展创造了良好的环境。

初期投资高

分子农业企业需要在基础设施、机械和技术方面进行大量的初始投资。高昂的初始成本对于新参与企业和小型企业来说可能是一个巨大的障碍。此外，透过分子农业生产的生物製药的监管核准过程可能很长且昂贵。公司还必须投资研发来优化生产流程并确保产品品质。这些经济挑战可能会阻碍分子农业市场的成长和扩张。

对植物性蛋白质的需求不断增加

出于健康、环境和道德的考虑，消费者的偏好正在转向植物来源饮食。这一趋势导致对植物蛋白的需求日益增长，植物蛋白被视为动物产品的永续且更健康的替代品。分子农业透过生产高品质的植物蛋白为满足这一需求提供了一个有希望的解决方案。此外，基因工程的进步使得生产具有特定营养和功能特性的客製化蛋白质成为可能。植物性饮食的日益普及为分子农业市场创造了巨大的成长机会。

易受环境因素影响

易受害虫、疾病和气候变迁等环境因素影响的农业系统是分子农业管理的基础。这些因素会影响作物产量、产品品质和整体生产力。例如，干旱和洪水等极端天气事件会毁坏作物并扰乱生产。此外，害虫和疾病能够迅速蔓延并对植物造成严重损害。降低这些风险需要强有力的农业实践、对有弹性的作物品种的投资以及有效的害虫管理策略。

COVID-19 的影响

COVID-19 疫情对分子农业市场产生了重大影响。这场疫情凸显了生物製药的重要性，并加速了新治疗方法和疫苗的开发。分子农业作为快速高效生产生物製药的潜在平台而备受关注。此外，疫情加速了对生物技术和医疗保健基础设施的投资，为分子农业技术创造了机会。然而，疫情期间供应链中断和物流挑战也为市场带来了障碍。

预计在预测期内，植物来源市场将成为最大的市场。

由于消费者对永续和健康食品的偏好增加，预计植物来源食品将在预测期内占据最大的市场占有率。透过分子农业生产的植物性蛋白质为传统动物性蛋白质提供了可行替代品。此外，植物蛋白的环境效益，如减少温室气体排放和减少资源使用，进一步推动了它的普及。人们对健康和环境问题的认识不断提高，推动了分子农业市场中植物来源产品的扩张。

预计预测期内製药业将实现最高的复合年增长率。

由于对创新且具有成本效益的药物、疫苗和透过分子农业生产的治疗性蛋白质的需求不断增长，预计製药业将在预测期内实现最高增长率。此外，分子农业可以快速生产治疗性蛋白质，以应对新出现的健康威胁。製药业专注于开发各种疾病（包括感染疾病和慢性病）的新治疗方法，从而推动了对分子农业技术的需求。

占比最大的地区：

预计预测期内亚太地区将占据最大的市场占有率。该地区庞大的人口和不断增长的医疗支出正在推动对先进生物製药的需求。此外，政府支持医疗保健和医学研究的措施也促进了市场的成长。强劲的生物技术产业和持续的研发投入进一步加强了亚太地区的分子农业市场。随着该地区的不断发展，对生物製药的需求预计将增加，使其成为分子农业技术的重要市场。

复合年增长率最高的地区：

预计北美地区在预测期内将呈现最高的复合年增长率。这是由于医疗保健基础设施不断发展以及老龄人口不断增加。该地区肌萎缩性脊髓侧索硬化症 (ALS) 和老年痴呆症症等神经退化性疾病的发生率正在增加，对 NfL 等准确、灵敏的生物标记的需求也随之增加。此外，北美拥有着名的製药和生物技术公司，促进了基于 NfL 的诊断测试和治疗性介入的开发和行销。

免费客製化服务

订阅此报告的客户可以选择以下免费自订选项之一：

  • 公司简介
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 主要企业的 SWOT 分析（最多 3 家公司）
  • 地理细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争性基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二手研究资料资讯来源
    • 先决条件

第三章 市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第 4 章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球分子农业市场按类型划分

  • 植物来源
  • 动物来源
  • 其他类型

6. 全球分子农业市场规模

  • 中试生产
  • 实验室规模生产
  • 商业规模生产

7. 全球分子农业市场（依作物来源）

  • 玉米
  • 大麦
  • 烟草
  • 红花
  • 米
  • 紫花苜蓿
  • 其他作物来源

8. 全球分子农业市场（依技术划分）

  • RNA干扰（RNAi）
  • 农桿菌介导的基因转移
  • 基因改造植物
  • 农桿菌浸润法
  • 电穿孔
  • 其他技术

9. 全球分子农业市场（按应用）

  • 食品和饲料
  • 工业酵素
  • 营养补充品
  • 乳製品
  • 其他用途

第 10 章 全球分子农业市场（依最终用户划分）

  • 农业产业
  • 生技及製药公司
  • 研究和学术机构
  • 契约製造组织（CMO）
  • 其他最终用户

第 11 章 全球分子农业市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章 公司概况

  • Syngenta AG
  • Monsanto
  • Corteva Agriscience
  • Medicago Inc.
  • SAB Biotherapeutics
  • Zymergen
  • Mapp Biopharmaceuticals
  • Ventria Bioscience
  • ArcelorMittal
  • GreenGate Biotech
  • Evonik Industries
  • NexBio
  • BASF SE
  • Tobacco Biotechnology Company（TBC）
  • Kirin Holdings Company, Ltd.
Product Code: SMRC28903

According to Stratistics MRC, the Global Molecular Farming Market is accounted for $531.75 million in 2024 and is expected to reach $1371.03 million by 2030 growing at a CAGR of 17.1% during the forecast period. Molecular farming is the process of producing useful bioproducts including proteins, vaccines, enzymes, and biofuels by using genetically engineered plants, microbes, or algae. It offers a scalable and affordable substitute for conventional production techniques by introducing particular genes into organisms to allow them to synthesis desired chemicals. Molecular farming is being used more and more in the pharmaceutical, agricultural, and industrial sectors. It is promoting biotechnology advancements and helping to provide sustainable solutions for energy, food production, and medicine.

Market Dynamics:

Driver:

Growing demand for biopharmaceuticals

The need for biopharmaceuticals is growing along with the prevalence of chronic diseases like diabetes, cancer, and cardiovascular disorders. Biopharmaceuticals offer targeted and effective treatments, driving growth in the molecular farming market. Additionally, advancements in biotechnology and genetic engineering have made it possible to produce complex proteins and antibodies using plant-based systems. These systems are often more cost-effective and scalable compared to traditional methods. The growing biopharmaceutical market creates a favourable environment for molecular farming technologies to thrive.

Restraint:

High initial investment

Molecular farming enterprises involve a large initial investment in infrastructure, machinery, and technology. This high initial cost can be a significant barrier for new entrants and smaller companies. Additionally, the regulatory approval process for biopharmaceuticals produced through molecular farming can be lengthy and expensive. Companies must also invest in research and development to optimize production processes and ensure product quality. These financial challenges can hinder the growth and expansion of the molecular farming market.

Opportunity:

Rising demand for plant-based proteins

Consumer preferences are shifting towards plant-based diets, driven by health, environmental, and ethical considerations. This trend has led to a growing demand for plant-based proteins, which are seen as sustainable and healthy alternatives to animal-based products. Molecular farming offers a promising solution to meet this demand by producing high-quality plant-based proteins. Additionally, advancements in genetic engineering enable the production of customized proteins with specific nutritional and functional properties. The increasing popularity of plant-based diets presents a significant growth opportunity for the molecular farming market.

Threat:

Vulnerability to environmental factors

Agricultural systems that are susceptible to environmental factors including pests, diseases, and climate change are the basis of molecular farming operations. These factors can impact crop yields, product quality, and overall productivity. For example, extreme weather events such as droughts or floods can devastate crops and disrupt production. Additionally, pests and diseases can spread rapidly and cause significant damage to plants. Mitigating these risks requires robust agricultural practices, investment in resilient crop varieties, and effective pest and disease management strategies.

Covid-19 Impact

The COVID-19 pandemic has had a profound impact on the molecular farming market. The pandemic has highlighted the importance of biopharmaceuticals and accelerated the development of new therapies and vaccines. Molecular farming has gained attention as a potential platform for producing biopharmaceuticals quickly and efficiently. Additionally, the pandemic has spurred investment in biotechnology and healthcare infrastructure, creating opportunities for molecular farming technologies. However, supply chain disruptions and logistical challenges during the pandemic have also posed obstacles for the market.

The plant-based segment is expected to be the largest during the forecast period

The plant-based segment is expected to account for the largest market share during the forecast period, due to the increasing consumer preference for sustainable and healthy food products. Plant-based proteins produced through molecular farming offer a viable alternative to traditional animal-based proteins. Additionally, the environmental benefits of plant-based proteins, such as reduced greenhouse gas emissions and lower resource usage, further drive their popularity. The growing awareness of health and environmental issues supports the expansion of the plant-based segment in the molecular farming market.

The pharmaceuticals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pharmaceuticals segment is predicted to witness the highest growth rate, due to the rising need for innovative and cost-effective drugs, vaccines, and therapeutic proteins produced through molecular farming. Furthermore, molecular farming allows for the rapid production of therapeutic proteins in response to emerging health threats. The pharmaceutical industry's focus on developing new treatments for various diseases, including infectious diseases and chronic conditions, drives the demand for molecular farming technologies.

Region with largest share:

During the forecast period, Asia Pacific region is expected to hold the largest market share, due to the region's large population and increasing healthcare expenditure drive the demand for advanced biopharmaceuticals. Additionally, government initiatives to support healthcare and medical research contribute to the market's growth. The presence of a robust biotechnology industry and ongoing investments in R&D further bolster the molecular farming market in the Asia Pacific region. As the region continues to develop, the demand for biopharmaceuticals is expected to increase, making it a crucial market for molecular farming technologies.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to a developed healthcare infrastructure, a growing senior population. The increasing incidence of neurodegenerative illnesses like ALS and Alzheimer's in the area has raised the need for precise and sensitive biomarkers like NfL. Furthermore, the development and marketing of NfL-based diagnostic tests and therapeutic interventions have been expedited by the presence of prominent pharmaceutical and biotechnology firms in North America.

Key players in the market

Some of the key players profiled in the Molecular Farming Market include Syngenta AG, Monsanto, Corteva Agriscience, Medicago Inc., SAB Biotherapeutics, Zymergen, Mapp Biopharmaceuticals, Ventria Bioscience, ArcelorMittal, GreenGate Biotech, Evonik Industries, NexBio, BASF SE, Tobacco Biotechnology Company (TBC), and Kirin Holdings Company, Ltd.

Key Developments:

In November 2024, McDonald's USA, syngenta and lopez foods collaborate to help produce beef more sustainably in the US, Syngenta, McDonald's and Lopez Foods announce collaboration aimed at helping to reduce certain environmental impacts during beef production.

In November 2024, Corteva Inc. announced a collaboration with bp on the companies' shared intent to form a crop-based biofuel feedstock joint venture (JV). The JV envisaged by Corteva and bp would produce and deliver crop-based biofuel feedstocks to help meet the anticipated growth in demand for 'sustainable aviation fuel' (SAF).

Types Covered:

  • Plant-Based
  • Animal-Based
  • Other Types

Scales Covered:

  • Pilot-Scale Production
  • Lab-Scale Production
  • Commercial-Scale Production

Crop Sources Covered:

  • Maize
  • Barley
  • Tobacco
  • Safflower
  • Rice
  • Alfalfa
  • Other Crop Sources

Technologies Covered:

  • RNA Interference (RNAi)
  • Agrobacterium-Mediated Gene Transfer
  • Transgenic Plants
  • Agroinfiltration
  • Electroporation
  • Other Technologies

Applications Covered:

  • Food & Feed
  • Industrial Enzymes
  • Nutraceuticals
  • Dairy
  • Other Applications

End Users Covered:

  • Agricultural Industry
  • Biotechnology & Pharmaceutical Companies
  • Research Institutions & Academia
  • Contract Manufacturing Organizations (CMOs)
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Molecular Farming Market, By Type

  • 5.1 Introduction
  • 5.2 Plant-Based
  • 5.3 Animal-Based
  • 5.4 Other Types

6 Global Molecular Farming Market, By Scale

  • 6.1 Introduction
  • 6.2 Pilot-Scale Production
  • 6.3 Lab-Scale Production
  • 6.4 Commercial-Scale Production

7 Global Molecular Farming Market, By Crop Source

  • 7.1 Introduction
  • 7.2 Maize
  • 7.3 Barley
  • 7.4 Tobacco
  • 7.5 Safflower
  • 7.6 Rice
  • 7.7 Alfalfa
  • 7.8 Other Crop Sources

8 Global Molecular Farming Market, By Technology

  • 8.1 Introduction
  • 8.2 RNA Interference (RNAi)
  • 8.3 Agrobacterium-Mediated Gene Transfer
  • 8.4 Transgenic Plants
  • 8.5 Agroinfiltration
  • 8.6 Electroporation
  • 8.7 Other Technologies

9 Global Molecular Farming Market, By Application

  • 9.1 Introduction
  • 9.2 Food & Feed
  • 9.3 Industrial Enzymes
  • 9.4 Nutraceuticals
  • 9.5 Dairy
  • 9.6 Other Applications

10 Global Molecular Farming Market, By End User

  • 10.1 Introduction
  • 10.2 Agricultural Industry
  • 10.3 Biotechnology & Pharmaceutical Companies
  • 10.4 Research Institutions & Academia
  • 10.5 Contract Manufacturing Organizations (CMOs)
  • 10.6 Other End Users

11 Global Molecular Farming Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Syngenta AG
  • 13.2 Monsanto
  • 13.3 Corteva Agriscience
  • 13.4 Medicago Inc.
  • 13.5 SAB Biotherapeutics
  • 13.6 Zymergen
  • 13.7 Mapp Biopharmaceuticals
  • 13.8 Ventria Bioscience
  • 13.9 ArcelorMittal
  • 13.10 GreenGate Biotech
  • 13.11 Evonik Industries
  • 13.12 NexBio
  • 13.13 BASF SE
  • 13.14 Tobacco Biotechnology Company (TBC)
  • 13.15 Kirin Holdings Company, Ltd.

List of Tables

  • Table 1 Global Molecular Farming Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Molecular Farming Market Outlook, By Type (2022-2030) ($MN)
  • Table 3 Global Molecular Farming Market Outlook, By Plant-Based (2022-2030) ($MN)
  • Table 4 Global Molecular Farming Market Outlook, By Animal-Based (2022-2030) ($MN)
  • Table 5 Global Molecular Farming Market Outlook, By Other Types (2022-2030) ($MN)
  • Table 6 Global Molecular Farming Market Outlook, By Scale (2022-2030) ($MN)
  • Table 7 Global Molecular Farming Market Outlook, By Pilot-Scale Production (2022-2030) ($MN)
  • Table 8 Global Molecular Farming Market Outlook, By Lab-Scale Production (2022-2030) ($MN)
  • Table 9 Global Molecular Farming Market Outlook, By Commercial-Scale Production (2022-2030) ($MN)
  • Table 10 Global Molecular Farming Market Outlook, By Crop Source (2022-2030) ($MN)
  • Table 11 Global Molecular Farming Market Outlook, By Maize (2022-2030) ($MN)
  • Table 12 Global Molecular Farming Market Outlook, By Barley (2022-2030) ($MN)
  • Table 13 Global Molecular Farming Market Outlook, By Tobacco (2022-2030) ($MN)
  • Table 14 Global Molecular Farming Market Outlook, By Safflower (2022-2030) ($MN)
  • Table 15 Global Molecular Farming Market Outlook, By Rice (2022-2030) ($MN)
  • Table 16 Global Molecular Farming Market Outlook, By Alfalfa (2022-2030) ($MN)
  • Table 17 Global Molecular Farming Market Outlook, By Other Crop Sources (2022-2030) ($MN)
  • Table 18 Global Molecular Farming Market Outlook, By Technology (2022-2030) ($MN)
  • Table 19 Global Molecular Farming Market Outlook, By RNA Interference (RNAi) (2022-2030) ($MN)
  • Table 20 Global Molecular Farming Market Outlook, By Agrobacterium-Mediated Gene Transfer (2022-2030) ($MN)
  • Table 21 Global Molecular Farming Market Outlook, By Transgenic Plants (2022-2030) ($MN)
  • Table 22 Global Molecular Farming Market Outlook, By Agroinfiltration (2022-2030) ($MN)
  • Table 23 Global Molecular Farming Market Outlook, By Electroporation (2022-2030) ($MN)
  • Table 24 Global Molecular Farming Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 25 Global Molecular Farming Market Outlook, By Application (2022-2030) ($MN)
  • Table 26 Global Molecular Farming Market Outlook, By Food & Feed (2022-2030) ($MN)
  • Table 27 Global Molecular Farming Market Outlook, By Industrial Enzymes (2022-2030) ($MN)
  • Table 28 Global Molecular Farming Market Outlook, By Nutraceuticals (2022-2030) ($MN)
  • Table 29 Global Molecular Farming Market Outlook, By Dairy (2022-2030) ($MN)
  • Table 30 Global Molecular Farming Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 31 Global Molecular Farming Market Outlook, By End User (2022-2030) ($MN)
  • Table 32 Global Molecular Farming Market Outlook, By Agricultural Industry (2022-2030) ($MN)
  • Table 33 Global Molecular Farming Market Outlook, By Biotechnology & Pharmaceutical Companies (2022-2030) ($MN)
  • Table 34 Global Molecular Farming Market Outlook, By Research Institutions & Academia (2022-2030) ($MN)
  • Table 35 Global Molecular Farming Market Outlook, By Contract Manufacturing Organizations (CMOs) (2022-2030) ($MN)
  • Table 36 Global Molecular Farming Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.